Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (73)	9/15/2000 12:17:58 AM
From: tommysdad	Read Replies (1) of 598

<<Arena and 3-Dimensional Pharm.>> Sorry, should have been more clear. I was inquiring after other players in the nuclear orphan area. Not familiar with 3-D, but Arena is the "CART technology" company, right? They're only looking at GPCRs at this time. (One has to question the viability of this technology for drug discovery . . . but perhaps an ARNA is in order) Anyway, what gets me about the nuclear orphan crowd (TLRK/GLX/X-ceptor) is that they all seem to have gravitated to the same few targets -- LXR & FXR. Isn't anyone looking anywhere else? Do Tularik and X-Ceptor really think they're going to beat Glaxo to the punch?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next